Current status and future prospects for epigenetic psychopharmacology

References

• Van, Speybroeck L. From epigenesis to epigenetics: the case of C. H. Waddington. Ann N Y Acad Sci 2002; 981:61 - 81; PMID: 12547674
   PubMed Web of Science ®Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33:Suppl 245 - 54; http://dx.doi.org/10.1038/ng1089; PMID: 12610534
   PubMed Web of Science ®Google Scholar
• Mikaelsson MA, Miller CA. DNA methylation: a transcriptional mechanism co-opted by the developed mammalian brain?. Epigenetics 2011; 6:548 - 51; http://dx.doi.org/10.4161/epi.6.5.15679; PMID: 21527830
   PubMed Web of Science ®Google Scholar
• Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008; 82:696 - 711; http://dx.doi.org/10.1016/j.ajhg.2008.01.008; PMID: 18319075
   PubMed Web of Science ®Google Scholar
• Kuwabara T, Hsieh J, Nakashima K, Taira K, Gage FH. A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 2004; 116:779 - 93; http://dx.doi.org/10.1016/S0092-8674(04)00248-X; PMID: 15035981
   PubMed Web of Science ®Google Scholar
• Zhao X, Ueba T, Christie BR, Barkho B, McConnell MJ, Nakashima K, et al. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci USA 2003; 100:6777 - 82; http://dx.doi.org/10.1073/pnas.1131928100; PMID: 12748381
   PubMed Web of Science ®Google Scholar
• Fan G, Beard C, Chen RZ, Csankovszki G, Sun Y, Siniaia M, et al. DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J Neurosci 2001; 21:788 - 97; PMID: 11157065
   PubMed Web of Science ®Google Scholar
• Wu JI, Lessard J, Olave IA, Qiu Z, Ghosh A, Graef IA, et al. Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 2007; 56:94 - 108; http://dx.doi.org/10.1016/j.neuron.2007.08.021; PMID: 17920018
   PubMed Web of Science ®Google Scholar
• Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008; 105:17046 - 9; http://dx.doi.org/10.1073/pnas.0806560105; PMID: 18955703
   PubMed Web of Science ®Google Scholar
• Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7:847 - 54; http://dx.doi.org/10.1038/nn1276; PMID: 15220929
   PubMed Web of Science ®Google Scholar
• Bateson P, Barker D, Clutton-Brock T, Deb D, D'Udine B, Foley RA, et al. Developmental plasticity and human health. Nature 2004; 430:419 - 21; http://dx.doi.org/10.1038/nature02725; PMID: 15269759
   PubMed Web of Science ®Google Scholar
• Rutten BP, Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr Bull 2009; 35:1045 - 56; http://dx.doi.org/10.1093/schbul/sbp104; PMID: 19783603
   PubMed Web of Science ®Google Scholar
• Mill J, Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol Psychiatry 2007; 12:799 - 814; http://dx.doi.org/10.1038/sj.mp.4001992; PMID: 17420765
   PubMed Web of Science ®Google Scholar
• Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 2007; 23:297 - 307; http://dx.doi.org/10.1016/j.reprotox.2006.08.012; PMID: 17046196
   PubMed Web of Science ®Google Scholar
• Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity 2010; 105:4 - 13; http://dx.doi.org/10.1038/hdy.2010.54; PMID: 20461105
   PubMed Web of Science ®Google Scholar
• Sleiman SF, Basso M, Mahishi L, Kozikowski AP, Donohoe ME, Langley B, et al. Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin Investig Drugs 2009; 18:573 - 84; http://dx.doi.org/10.1517/13543780902810345; PMID: 19388875
   PubMed Web of Science ®Google Scholar
• Hahnen E, Hauke J, Trankle C, Eyupoglu IY, Wirth B, Blumcke I. Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 2008; 17:169 - 84; http://dx.doi.org/10.1517/13543784.17.2.169; PMID: 18230051
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693 - 705; http://dx.doi.org/10.1016/j.cell.2007.02.005; PMID: 17320507
   PubMed Web of Science ®Google Scholar
• Mosammaparast N, Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 2010; 79:155 - 79; http://dx.doi.org/10.1146/annurev.biochem.78.070907.103946; PMID: 20373914
   PubMed Web of Science ®Google Scholar
• Ebert A, Lein S, Schotta G, Reuter G. Histone modification and the control of heterochromatic gene silencing in Drosophila. Chromosome Res 2006; 14:377 - 92; http://dx.doi.org/10.1007/s10577-006-1066-1; PMID: 16821134
   PubMed Web of Science ®Google Scholar
• Renthal W, Nestler EJ. Chromatin regulation in drug addiction and depression. Dialogues Clin Neurosci 2009; 11:257 - 68; PMID: 19877494
   PubMedGoogle Scholar
• Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324:929 - 30; http://dx.doi.org/10.1126/science.1169786; PMID: 19372393
   PubMed Web of Science ®Google Scholar
• Globisch D, Munzel M, Muller M, Michalakis S, Wagner M, Koch S, et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 2010; 5:e15367; http://dx.doi.org/10.1371/journal.pone.0015367; PMID: 21203455
   PubMed Web of Science ®Google Scholar
• Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010; 466:253 - 7; http://dx.doi.org/10.1038/nature09165; PMID: 20613842
   PubMed Web of Science ®Google Scholar
• Deaton AM, Webb S, Kerr AR, Illingworth RS, Guy J, Andrews R, et al. Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res 2011; 21:1074 - 86; http://dx.doi.org/10.1101/gr.118703.110; PMID: 21628449
   PubMed Web of Science ®Google Scholar
• Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010; 464:1082 - 6; http://dx.doi.org/10.1038/nature08924; PMID: 20393567
   PubMed Web of Science ®Google Scholar
• Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9:519 - 25; http://dx.doi.org/10.1038/nn1659; PMID: 16501568
   PubMed Web of Science ®Google Scholar
• Wilkinson MB, Xiao G, Kumar A, LaPlant Q, Renthal W, Sikder D, et al. Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci 2009; 29:7820 - 32; http://dx.doi.org/10.1523/JNEUROSCI.0932-09.2009; PMID: 19535594
   PubMed Web of Science ®Google Scholar
• Perisic T, Zimmermann N, Kirmeier T, Asmus M, Tuorto F, Uhr M, et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 2010; 35:792 - 805; http://dx.doi.org/10.1038/npp.2009.188; PMID: 19924110
   PubMed Web of Science ®Google Scholar
• Mao X, Hou T, Cao B, Wang W, Li Z, Chen S, et al. The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence. Mol Pharmacol 2011; 79:672 - 80; http://dx.doi.org/10.1124/mol.110.068122; PMID: 21220410
   PubMed Web of Science ®Google Scholar
• Hunter RG, McCarthy KJ, Milne TA, Pfaff DW, McEwen BS. Regulation of hippocampal H3 histone methylation by acute and chronic stress. Proc Natl Acad Sci U S A. 2009.
   Google Scholar
• Karpova NN, Lindholm J, Pruunsild P, Timmusk T, Castren E. Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol 2009; 19:97 - 108; http://dx.doi.org/10.1016/j.euroneuro.2008.09.002; PMID: 18973993
   PubMed Web of Science ®Google Scholar
• Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB, et al. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 2006; 70:487 - 92; http://dx.doi.org/10.1124/mol.106.022301; PMID: 16670375
   PubMed Web of Science ®Google Scholar
• Covington HE III, Vialou VF, LaPlant Q, Ohnishi YN, Nestler EJ. Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition. Neurosci Lett 2011; 493:122 - 6; http://dx.doi.org/10.1016/j.neulet.2011.02.022; PMID: 21335060
   PubMed Web of Science ®Google Scholar
• Melas PA, Rogdaki M, Lennartsson A, Bjork K, Qi H, Witasp A, et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol 2011; 1 - 11; http://dx.doi.org/10.1017/S1461145711000940; PMID: 21682946
   PubMed Web of Science ®Google Scholar
• Culhane JC, Wang D, Yen PM, Cole PA. Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc 2010; 132:3164 - 76; http://dx.doi.org/10.1021/ja909996p; PMID: 20148560
   PubMed Web of Science ®Google Scholar
• Binda C, Valente S, Romanenghi M, Pilotto S, Cirilli R, Karytinos A, et al. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. J Am Chem Soc 2010; 132:6827 - 33; http://dx.doi.org/10.1021/ja101557k; PMID: 20415477
   PubMed Web of Science ®Google Scholar
• Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 2006; 13:563 - 7; http://dx.doi.org/10.1016/j.chembiol.2006.05.004; PMID: 16793513
   PubMed Web of Science ®Google Scholar
• Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, et al. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 2004; 90:1117 - 31; http://dx.doi.org/10.1111/j.1471-4159.2004.02569.x; PMID: 15312167
   PubMed Web of Science ®Google Scholar
• Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Herve D, Valjent E, et al. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 2008; 28:5671 - 85; http://dx.doi.org/10.1523/JNEUROSCI.1039-08.2008; PMID: 18509028
   PubMed Web of Science ®Google Scholar
• Bertran-Gonzalez J, Hakansson K, Borgkvist A, Irinopoulou T, Brami-Cherrier K, Usiello A, et al. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology 2009; 34:1710 - 20; http://dx.doi.org/10.1038/npp.2008.228; PMID: 19158668
   PubMed Web of Science ®Google Scholar
• Shimabukuro M, Jinno Y, Fuke C, Okazaki Y. Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav Brain Funct 2006; 2:37; http://dx.doi.org/10.1186/1744-9081-2-37; PMID: 17132176
   PubMedGoogle Scholar
• Dong E, Nelson M, Grayson DR, Costa E, Guidotti A. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci USA 2008; 105:13614 - 9; http://dx.doi.org/10.1073/pnas.0805493105; PMID: 18757738
   PubMed Web of Science ®Google Scholar
• Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP, et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 2007; 27:11254 - 62; http://dx.doi.org/10.1523/JNEUROSCI.3272-07.2007; PMID: 17942719
   PubMed Web of Science ®Google Scholar
• Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, et al. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 2011; 60:1007 - 16; http://dx.doi.org/10.1016/j.neuropharm.2010.10.021; PMID: 21074545
   PubMed Web of Science ®Google Scholar
• Matrisciano F, Dong E, Gavin DP, Nicoletti F, Guidotti A. Activation of Group II Metabotropic Glutamate Receptors Promotes DNA Demethylation in the Mouse Brain. Mol Pharmacol 2011; 80:174 - 82; http://dx.doi.org/10.1124/mol.110.070896; PMID: 21505039
   PubMed Web of Science ®Google Scholar
• Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E, et al. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci USA 2006; 103:1587 - 92; http://dx.doi.org/10.1073/pnas.0510341103; PMID: 16432198
   PubMed Web of Science ®Google Scholar
• Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, et al. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 2004; 90:1117 - 31; http://dx.doi.org/10.1111/j.1471-4159.2004.02569.x; PMID: 15312167
   PubMed Web of Science ®Google Scholar
• D'Souza A, Onem E, Patel P, La Gamma EF, Nankova BB. Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res 2009; 1247:1 - 10; http://dx.doi.org/10.1016/j.brainres.2008.09.088; PMID: 18976638
   PubMed Web of Science ®Google Scholar
• Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, Takasaki I, et al. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 2009; 65:35 - 43; http://dx.doi.org/10.1016/j.neures.2009.05.002; PMID: 19463867
   PubMed Web of Science ®Google Scholar
• Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, et al. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 2008; 11:1123 - 34; http://dx.doi.org/10.1017/S1461145708009024; PMID: 18611290
   PubMed Web of Science ®Google Scholar
• Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 2009; 14:51 - 9; http://dx.doi.org/10.1038/sj.mp.4002099; PMID: 17925795
   PubMed Web of Science ®Google Scholar
• Morita K, Gotohda T, Arimochi H, Lee MS, Her S. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. J Neurosci Res 2009; 87:2608 - 14; http://dx.doi.org/10.1002/jnr.22072; PMID: 19360904
   PubMed Web of Science ®Google Scholar
• Sharma RP, Rosen C, Kartan S, Guidotti A, Costa E, Grayson DR, et al. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr Res 2006; 88:227 - 31; http://dx.doi.org/10.1016/j.schres.2006.07.015; PMID: 16996718
   PubMed Web of Science ®Google Scholar
• Kundakovic M, Chen Y, Guidotti A, Grayson DR. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 2009; 75:342 - 54; http://dx.doi.org/10.1124/mol.108.051763; PMID: 19029285
   PubMed Web of Science ®Google Scholar
• Gavin DP, Kartan S, Chase K, Jayaraman S, Sharma RP. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J Psychiatr Res 2009; 43:870 - 6; http://dx.doi.org/10.1016/j.jpsychires.2008.12.006; PMID: 19187942
   PubMed Web of Science ®Google Scholar
• Yu IT, Park JY, Kim SH, Lee JS, Kim YS, Son H. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009; 56:473 - 80; http://dx.doi.org/10.1016/j.neuropharm.2008.09.019; PMID: 19007798
   PubMed Web of Science ®Google Scholar
• Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 2009; 30:55 - 60; http://dx.doi.org/10.1016/j.tips.2008.10.010; PMID: 19110320
   PubMed Web of Science ®Google Scholar
• Veldic M, Kadriu B, Maloku E, Agis-Balboa RC, Guidotti A, Davis JM, et al. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 2007; 91:51 - 61; http://dx.doi.org/10.1016/j.schres.2006.11.029; PMID: 17270400
   PubMed Web of Science ®Google Scholar
• Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res 2002; 30:2930 - 9; http://dx.doi.org/10.1093/nar/gkf401; PMID: 12087179
   PubMed Web of Science ®Google Scholar
• Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem 2005; 93:483 - 92; http://dx.doi.org/10.1111/j.1471-4159.2005.03040.x; PMID: 15816871
   PubMed Web of Science ®Google Scholar
• Dong E, Guidotti A, Grayson DR, Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci USA 2007; 104:4676 - 81; http://dx.doi.org/10.1073/pnas.0700529104; PMID: 17360583
   PubMed Web of Science ®Google Scholar
• Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 2005; 102:12578 - 83; http://dx.doi.org/10.1073/pnas.0505394102; PMID: 16113080
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Doueiri MS, Dong E, Grayson DR, Davis J, Pinna G, et al. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 2005; 57:500 - 9; http://dx.doi.org/10.1016/j.biopsych.2004.11.046; PMID: 15737665
   PubMed Web of Science ®Google Scholar
• Kim B, Rincon Castro LM, Jawed S, Niles LP. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. Eur J Pharmacol 2008; 589:45 - 8; http://dx.doi.org/10.1016/j.ejphar.2008.04.058; PMID: 18550052
   PubMed Web of Science ®Google Scholar
• Shen HY, Kalda A, Yu L, Ferrara J, Zhu J, Chen JF. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice. Neuroscience 2008; 157:644 - 55; http://dx.doi.org/10.1016/j.neuroscience.2008.09.019; PMID: 18848971
   PubMed Web of Science ®Google Scholar
• Dickinson M, Johnstone RW, Prince HM. Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect. Invest New Drugs 2010; 28:Suppl 1 S3 - 20; http://dx.doi.org/10.1007/s10637-010-9596-y; PMID: 21161327
   PubMed Web of Science ®Google Scholar
• Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003; 133:2485S - 93S; PMID: 12840228
   PubMed Web of Science ®Google Scholar
• Stefanko DP, Barrett RM, Ly AR, Reolon GK, Wood MA. Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci USA 2009; 106:9447 - 52; http://dx.doi.org/10.1073/pnas.0903964106; PMID: 19470462
   PubMed Web of Science ®Google Scholar
• Gupta S, Kim SY, Artis S, Molfese DL, Schumacher A, Sweatt JD, et al. Histone methylation regulates memory formation. J Neurosci 2010; 30:3589 - 99; http://dx.doi.org/10.1523/JNEUROSCI.3732-09.2010; PMID: 20219993
   PubMed Web of Science ®Google Scholar
• Lattal KM, Barrett RM, Wood MA. Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 2007; 121:1125 - 31; http://dx.doi.org/10.1037/0735-7044.121.5.1125; PMID: 17907845
   PubMed Web of Science ®Google Scholar
• Schroeder FA, Lin CL, Crusio WE, Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007; 62:55 - 64; http://dx.doi.org/10.1016/j.biopsych.2006.06.036; PMID: 16945350
   PubMed Web of Science ®Google Scholar
• Gundersen BB, Blendy JA. Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 2009; 57:67 - 74; http://dx.doi.org/10.1016/j.neuropharm.2009.04.008; PMID: 19393671
   PubMed Web of Science ®Google Scholar
• Kwon B, Houpt TA. Phospho-acetylation of histone H3 in the amygdala after acute lithium chloride. Brain Res 2010; 1333:36 - 47; http://dx.doi.org/10.1016/j.brainres.2010.03.068; PMID: 20346924
   PubMed Web of Science ®Google Scholar
• Patel P, Nankova BB, LaGamma EF. Butyrate, a gut-derived environmental signal, regulates tyrosine hydroxylase gene expression via a novel promoter element. Brain Res Dev Brain Res 2005; 160:53 - 62; http://dx.doi.org/10.1016/j.devbrainres.2005.08.005; PMID: 16165221
   PubMedGoogle Scholar
• Tian F, Marini AM, Lipsky RH. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. Ann N Y Acad Sci 2010; 1199:186 - 93; http://dx.doi.org/10.1111/j.1749-6632.2009.05175.x; PMID: 20633124
   PubMed Web of Science ®Google Scholar
• Weaver IC, D'Alessio AC, Brown SE, Hellstrom IC, Dymov S, Sharma S, et al. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J Neurosci 2007; 27:1756 - 68; http://dx.doi.org/10.1523/JNEUROSCI.4164-06.2007; PMID: 17301183
   PubMed Web of Science ®Google Scholar
• Weaver IC, Meaney MJ, Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 2006; 103:3480 - 5; http://dx.doi.org/10.1073/pnas.0507526103; PMID: 16484373
   PubMed Web of Science ®Google Scholar
• Covington HE 3rd, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009; 29:11451 - 60; http://dx.doi.org/10.1523/JNEUROSCI.1758-09.2009; PMID: 19759294
   PubMed Web of Science ®Google Scholar
• Sales AJ, Biojone C, Terceti MS, Guimaraes FS, Gomes MV, Joca SR. Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br J Pharmacol 2011; 164:1711 - 21; http://dx.doi.org/10.1111/j.1476-5381.2011.01489.x; PMID: 21585346
   PubMed Web of Science ®Google Scholar
• Kundakovic M, Chen Y, Costa E, Grayson DR. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol 2007; 71:644 - 53; http://dx.doi.org/10.1124/mol.106.030635; PMID: 17065238
   PubMed Web of Science ®Google Scholar
• Tian F, Hu XZ, Wu X, Jiang H, Pan H, Marini AM, et al. Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter 1. J Neurochem 2009; 109:1375 - 88; http://dx.doi.org/10.1111/j.1471-4159.2009.06058.x; PMID: 19476549
   PubMed Web of Science ®Google Scholar
• Sales AJ, Biojone C, Terceti MS, Guimaraes FS, Gomes MV, Joca SR. Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br J Pharmacol 2011; 164:1711 - 21; http://dx.doi.org/10.1111/j.1476-5381.2011.01489.x; PMID: 21585346
   PubMed Web of Science ®Google Scholar